Theriva Biologics, Inc. (TOVX)

Theriva Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.53	11.61	23.18	41.79	67.33	6.23
Cash & Short-Term Investments	7.53	11.61	23.18	41.79	67.33	6.23
Cash Growth	-54.12%	-49.91%	-44.53%	-37.93%	981.18%	-58.61%
Other Receivables	1.82	3.32	1.94	0.23	-	0.47
Receivables	1.82	3.32	1.94	0.23	-	0.47
Prepaid Expenses	0.55	0.98	1.17	1.21	1.08	0.77
Other Current Assets	-	0.37	1.12	2.29	0.46	0.47
Total Current Assets	9.9	16.28	27.4	45.52	68.86	7.93
Property, Plant & Equipment	1.19	1.54	2.18	1.54	1.48	0.45
Goodwill	-	-	5.7	5.53	-	-
Long-Term Deferred Charges	19.61	17.36	19.76	19.15	-	-
Other Long-Term Assets	0.13	0.17	0.18	0.12	0.02	0.02
Total Assets	30.84	35.35	55.22	71.86	70.37	8.41
Accounts Payable	0.8	0.86	0.77	0.92	0.52	0.89
Accrued Expenses	8.43	4.51	4.51	2.9	2.91	1.79
Current Portion of Long-Term Debt	0.06	0.06	0.06	0.06	-	-
Current Portion of Leases	0.62	0.54	0.49	0.22	0.12	0.29
Other Current Liabilities	1.1	1.61	0.91	2.97	-	-
Total Current Liabilities	11	7.59	6.74	7.06	3.55	2.97
Long-Term Debt	1.65	0.09	0.16	0.22	-	-
Long-Term Leases	0.43	0.87	1.44	1.19	1.4	0.19
Long-Term Deferred Tax Liabilities	-	-	-	1.62	-	-
Other Long-Term Liabilities	11.01	7.74	7.18	7.21	-	-
Total Liabilities	24.1	16.29	15.52	17.3	4.96	3.15
Common Stock	0.01	0	0	0.02	0.01	0.03
Additional Paid-In Capital	362.97	355.5	346.54	343.75	336.68	240.82
Retained Earnings	-356.71	-334.97	-309.32	-290.97	-271.28	-248.09
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-	-
Comprehensive Income & Other	0.76	-1.18	0.03	-0.68	-	-
Total Common Equity	6.74	19.07	36.96	51.83	65.41	-7.24
Minority Interest	-	-	-	-	-	-2.77
Shareholders' Equity	6.74	19.07	39.7	54.56	65.41	5.26
Total Liabilities & Equity	30.84	35.35	55.22	71.86	70.37	8.41
Total Debt	2.76	1.57	2.15	1.68	1.53	0.47
Net Cash (Debt)	4.77	10.04	21.02	40.11	65.8	5.75
Net Cash Growth	-67.51%	-52.22%	-47.58%	-39.05%	1043.52%	-59.83%
Net Cash Per Share	0.86	7.45	32.63	65.41	134.97	75.67
Filing Date Shares Outstanding	33.74	2.78	0.69	0.6	0.63	0.52
Total Common Shares Outstanding	10.3	2.78	0.69	0.6	0.53	0.12
Working Capital	-1.1	8.7	20.67	38.46	65.3	4.97
Book Value Per Share	0.65	6.85	53.89	85.67	123.84	-61.91
Tangible Book Value	6.74	19.07	31.26	46.31	65.41	-7.24
Tangible Book Value Per Share	0.65	6.85	45.58	76.54	123.84	-61.91
Machinery	0.69	0.71	0.9	0.9	0.83	0.81
Leasehold Improvements	0.09	0.09	0.09	0.09	0.09	0.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q